UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB (x) QUARTERLY REPORT UNDER SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2003 ------------------ Commission file number 0-30351 ------- TRUE HEALTH, INC. (Exact name of small business issuer as specified in its charter) Utah 75-2263732 (State or other jurisdiction of incorporation or (IRS Employer Identification No.) organization) 5 Tansey Circle, Mesquite, Texas 75149 (Address of principal executive offices) (972) 644-1200 (Issuer's telephone number) Securities registered pursuant to Section 12(g) of the Act: Common Stock, Par Value $0.01 Per Share Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No______ As of March 31, 2003, there were outstanding 258,393 shares of True Health, Inc., Common Stock, par value $.01. Transitional Small Business Disclosure Format (Check one):Yes No x FORM 10-QSB TRUE HEALTH, INC. Index to Form 10-QSB PART I FINANCIAL INFORMATION (UNAUDITED) ITEM 1. FINANCIAL STATEMENTS Balance Sheet as of March 31, 2003 Statements of Income (Loss) for the Three Months Ended March 31, 2003 and 2002 Statements of Cash flows for the Three Months Ended March 31, 2003 and 2002 Notes to Financial Statements ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS PART II OTHER INFORMATION Item 1 SIGNATURES TRUE HEALTH, INC. (A development stage enterprise) Balance Sheet March 31, 2003 (Unaudited) -------------------------------------------------------------------------------- March 31, 2003 -------------------- ASSETS Current assets: Cash $ 2,343 -------------------- Total assets $ 2,343 ==================== LIABILITIES Current liabilities: Accounts payable and accrued expenses $ 15,106 Due to related parties 12,900 -------------------- Total current liabilities 28,006 -------------------- STOCKHOLDERS' DEFICIT Common stock, $.01 par value, 100,000,000 shares authorized 258,393 shares issued and outstanding 2,584 Capital in excess of par value 1,010,375 Accumulated deficit: Prior operating accumulated deficit (1,032,540) Accumulated during the development stage (6,082) -------------------- Total stockholders' deficit (25,663) -------------------- Total liabilities and stockholders' equity $ 2,343 ==================== TRUE HEALTH, INC. (A development stage enterprise) Statements of Income (Loss) For The Periods Ended March 31, 2003 and 2002 (Unaudited) -------------------------------------------------------------------------------- Cumulative, January 1, 2003 Through March 31, Quarter Ended March 31, -------------------------------------------------- 2003 2003 2002 --------------------- ---------------------- ------------------------ Development stage operations: Revenues $ - $ - $ - --------------------- ---------------------- ------------------------ General and administrative expenses 6,018 6,018 - --------------------- ---------------------- ------------------------ Loss from operations (6,018) (6,018) - --------------------- ---------------------- ------------------------ Other income (expense), Interest expense (64) (64) - --------------------- ---------------------- ------------------------ Total other income (expense) (64) (64) - --------------------- ---------------------- ------------------------ Income (Loss) from development stage operations (6,082) (6,082) - Discontinued operations: (Loss) from discontinued operations - - (3,303) --------------------- ---------------------- ------------------------ Net income (loss) $ (6,082) $ (6,082) $ (3,303) ===================== ====================== ======================== Income (Loss) per common share, basic Continuing operations $ (0.02) - Discontinued operations - (0.04) ---------------------- ------------------------ $ (0.02) $ (0.04) ====================== ======================== Weighted average number of shares outstanding 258,393 94,016 ====================== ======================== TRUE HEALTH, INC. (A development stage enterprise) Statements of Cash Flows For The Periods Ended March 31, 2003 and 2002 (Unaudited) -------------------------------------------------------------------------------- Cumulative, January 1, 2003 Through March 31, Quarter Ended March 31, ---------------------------------------------- 2003 2003 2002 --------------------- ------------------- ---------------------- Cash flows from operating activities: Net income (loss) $ (6,082) $ (6,082) $ (3,303) Adjustments to reconcile net income to cash provided (used) by operating activities: Depreciation - - 62 Changes in current assets and liabilities: Inventory - - (374) Accounts payable and accrued expenses 4,657 4,657 3,673 --------------------- ------------------- ---------------------- Net cash flows from operating activities (1,425) (1,425) 58 --------------------- ------------------- ---------------------- Cash flows from investing activities - - - --------------------- ------------------- ---------------------- Cash flows from financing activities: Stock issued for services - - 10,000 Less, Amount recorded as prepaid expenses - - (10,000) Advances from related parties 2,900 2,900 (436) --------------------- ------------------- ---------------------- Net cash flows from financing activities 2,900 2,900 (436) --------------------- ------------------- ---------------------- Net increase (decrease) in cash and cash equivalents 1,475 1,475 (378) Cash and cash equivalents: Beginning of period 868 868 478 --------------------- ------------------- ---------------------- $ $ $ End of period 2,343 2,343 100 ===================== =================== ====================== Supplemental cash flow disclosures: Cash paid for interest $ - $ - $ - Cash paid for income taxes - - - Non-cash financing and investing activities: Stock issued for services - - 10,000 TRUE HEALTH, INC. NOTES TO UNAUDITED FINANCIAL STATEMENTS Note 1 - Basis of presentation: The financial statements include the accounts of True Health, Inc. The Balance Sheets as of March 31,2003, the Statements of Income (Loss) and the Statements of Cash Flows for the three months ended March 31, 2003 and 2002 have been prepared by the Company without audit. In the opinion of management, these financial statements include all adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods ended March 31, 2003 and 2002. All adjustments made have been of a normal recurring nature. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of financial position of operating results for an entire year. It is suggested that these interim financial statements be read in conjunction with the audited financial statements and the notes thereto included in the Company's Form 10-KSB for the year ended December 31, 2002 filed with the United States Securities and Exchange Commission (SEC) on or about April 15, 2003. Note 2 - The Company, nature of operations: True Health, Inc. (the Company) is a Utah corporation. Since January 1, 2003, the Company has not been engaged in an active business, and has been deemed to be in the development stage. As such, it is searching for equity and/or debt capital, and is exploring various business opportunities. Prior to December 31, 2002, it was an operating company engaged in marketing nutrition supplement/meal replacement products under the brand name of True Health Products. The accompanying financial statements have been prepared on the basis of U.S. generally accepted accounting principles applicable to development stage enterprises. Note 3 - Reverse split in common stock: Effective February 18, 2003, the Company effected a 1 for 65 reverse split of its common stock, under which each shareholder received 1 new share of stock for each 65 formerly held. The 1 for 65 reverse split has been retroactively presented in the accompanying financial statements. Note 4 - Going concern: The Company has experienced losses in eight of the previous ten years. Losses amount to more than $1,000,000 on a cumulative basis. At March 31, 2003, current liabilities exceeded current assets by approximately $25,000, resulting in a working capital deficiency; there is also a capital deficit of the same approximate amount. As indicated above, management is currently seeking outside financing and/or equity investors and is exploring business opportunities. However, there is no assurance that these efforts will be successful. Accordingly, the Company must rely on its officers and directors to perform essential functions without compensation until a business operation can be commenced. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS RESULTS OF OPERATIONS The company had no sales year-to-date for the three months ending March 31, 2003, versus $6,336 for the same period of 2002. During the quarter ended March 31, 2003, sales were down $6,336 from the preceding year. The decrease in sales resulted primarily from Company management's focus on raising additional equity capital. Year-to-date selling, general, and administrative expenses decreased to $6,082 from $8,372, primarily due to management's ability to control costs. Year-to-date net loss increased to $6,082 from $3,303. The Company had total assets of $2,343 at March 31, 2003, compared to $868 at December 31, 2002, an insignificant change. Part II - Other Information ITEM 1 - Legal Proceedings: None. ITEM 2 - Changes in Securities: In February 2003, the Company completed a reverse stock split whereby each sixty-five (65) shares of the Corporation's $0.01 par value common stock outstanding were converted into one (1) share of the Corporation's $0.01 par value common stock. Concurrently therewith, the Company's ticker symbol changed from TRHH to TRHL. ITEM 3 - Defaults Upon Senior Securities: None. ITEM 4 - Submission of Matters to a Vote of Security Holders: The Company had no matters put to a vote of the security holders during the first quarter. ITEM 5 - Other Information: This form 10-QSB includes or may include certain forward-looking statements concerning the Company's financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations as well as other statements including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions. Although the Company believes its expectations reflected in such forward-looking statements are based on reasonable assumptions, readers are cautioned that no assurance can be given that such expectations will prove correct and that actual results and developments may differ materially from those conveyed in such forward-looking statements. Important factors that could cause actual results to differ materially from the expectations reflected in the forward-looking statements in the Form 10-SB include, among others, the pace of technological change, the Company's ability to manage growth, general business and economic conditions in the Company's operating regions, and competitive and other factors, all as more fully described in the Company's Report on Form 10-SB for the period ended December 31, 2001, under Management's Discussion and Analysis of Financial Condition and Results of Operations. "Assumptions Underlying Certain Forward-Looking Statements and Factors that May Affect Future Results" and elsewhere from time to time in the Company's other SEC reports. Such forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Form 10-QSB. If the Company does update or correct one or more forward-looking statements, investors and others should not conclude that the Company would make additional updates or corrections with respect thereto or with respect to other forward-looking statements. Actual results may vary materially. ITEM 6. Exhibits And Reports On Form 8-K: None. SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. True Health, Inc. ----------------- (Registrant) Date: May 20,2003 By: /s/ Richard M. Stokley, President (Signature) Richard M. Stokley, President CERTIFICATION I, Richard M. Stokley, certify that: 1. I have reviewed this quarterly report on Form 10-Q of True Health, Inc., a. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and 2. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report. 3. I am responsible for the establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: a. designed such disclosure controls and procedures to ensure that material information relating to the registrant is made known to me, particularly during the period in which this quarterly report is being prepared; b. evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and c. presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; 4. I have disclosed, based on my most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing equivalent function): a. all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal ontrols; and b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and 5. I have indicated in this quarterly report whether or not there were significant changes in internal controls or in factors that could significantly affect internal controls subsequent to the date of my most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. Date: May 20, 2003 By: /s/ Richard M. Stokley Richard M. Stokley President